ADC Therapeutics SA
NYSE:ADCT
Gross Margin
ADC Therapeutics SA
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
Gross Margin Comparison
ADC Therapeutics SA Competitors
Country | CH |
Market Cap | 346.6m USD |
Gross Margin |
96%
|
Country | US |
Market Cap | 319.7B USD |
Gross Margin |
66%
|
Country | US |
Market Cap | 153.2B USD |
Gross Margin |
70%
|
Country | US |
Market Cap | 108.4B USD |
Gross Margin |
87%
|
Country | US |
Market Cap | 105.1B USD |
Gross Margin |
86%
|
Country | US |
Market Cap | 91.4B USD |
Gross Margin |
78%
|
Country | AU |
Market Cap | 139.1B AUD |
Gross Margin |
52%
|
Country | US |
Market Cap | 43.1B USD |
Gross Margin |
75%
|
Country | US |
Market Cap | 41.6B USD |
Gross Margin |
31%
|
Country | US |
Market Cap | 31.2B USD |
Gross Margin |
74%
|
Country | KR |
Market Cap | 40.1T KRW |
Gross Margin |
48%
|
Gross Margin Distribution
Gross Margin Distribution
Biotechnology Industry
Profitability Report
View the profitability report to see the full profitability analysis for ADC Therapeutics SA.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on ADC Therapeutics SA's most recent financial statements, the company has Gross Margin of 96.4%.